Stock BPCP BIOPHARMA CREDIT PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights BioPharma Credit PLC

Equities

BPCP

GB00BDGKMY29

Market Closed - London S.E.
Other stock markets
 11:35:23 2024-06-10 am EDT 		5-day change 1st Jan Change
0.846 USD +0.24% Intraday chart for BioPharma Credit PLC +0.48% +0.71%
May. 02 BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg MT
May. 02 BioPharma Credit agrees USD400 million loan for oncology firm Novacure AN

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg
MT
BioPharma Credit agrees USD400 million loan for oncology firm Novacure
AN
BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals
AN
BioPharma Credit PLC Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioPharma Credit net asset value ticks up but total payout lower
AN
Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.
CI
Biopharma Credit plc Declares Interim Dividend in Respect of the Financial Period Ending 31 March 2024, Payable on 30 April 2024
CI
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase
AN
Biopharma Credit Secures $51 Million Loan Repayment from US Biotech ImmunoGen
MT
BioPharma Credit PLC Declares Interim Special Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024
CI
BioPharma Credit PLC Declares Ordinary Interim Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024
CI
Barratt takes over Redrow in GBP2.5 billion deal
AN
BioPharma Credit to receive partial prepayment of loan
AN
BioPharma Credit to fund LumiraDx ahead of acquisition by Roche
AN
BioPharma Credit notes AbbVie takeover of investee ImmunoGen
AN
Biopharma Credit plc Declares Special Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024
CI
BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024
CI
BioPharma Credit PLC Reports Earnings Results for the Half Year Ended June 30, 2023
CI
BioPharma Credit hails "attractive pipeline" and backs dividend target
AN
BioPharma Credit PLC Provides Dividend Guidance for the Full Year Ending December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BPCP Stock
  4. News BioPharma Credit PLC
  5. Highlights